SEC Form 4 · accession 0001225208-19-004829
Cigna Group · CI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Cordani
Officer — President & CEO · Director
Period of report
Mar 4, 2019
Accepted (ET)
Mar 6, 2019 · 7:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001739940
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par ValueF2 | Mar 4, 2019 | S | 500 | $175.8836 | D | 350,207 | D | |
| Common Stock, $.01 Par ValueF3 | Mar 4, 2019 | S | 700 | $177.3286 | D | 349,507 | D | |
| Common Stock, $.01 Par ValueF4 | Mar 4, 2019 | S | 800 | $178.3638 | D | 348,707 | D | |
| Common Stock, $.01 Par ValueF5 | Mar 4, 2019 | S | 2,335 | $175.3028 | D | 346,372 | D | |
| Common Stock, $.01 Par ValueF6 | Mar 4, 2019 | S | 3,414 | $171.9732 | D | 342,958 | D | |
| Common Stock, $.01 Par ValueF7 | Mar 4, 2019 | S | 6,491 | $172.9807 | D | 336,467 | D | |
| Common Stock, $.01 Par ValueF8 | Mar 4, 2019 | S | 13,062 | $174.1848 | D | 323,405 | D | |
| Common Stock, $.01 Par ValueF9 | holding | — | — | — | 1,640 | I | By 401(k) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018.
- F2Represents the weighted average price of the shares sold. The prices actually received ranged from $175.768 to $176.08 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F3Represents the weighted average price of the shares sold. The prices actually received ranged from $177.205 to $177.53 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F4Represents the weighted average price of the shares sold. The prices actually received ranged from $178.21 to $178.495 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F5Represents the weighted average price of the shares sold. The prices actually received ranged from $174.77 to $175.73 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F6Represents the weighted average price of the shares sold. The prices actually received ranged from $171.64 to $172.55 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F7Represents the weighted average price of the shares sold. The prices actually received ranged from $172.68 to $173.62 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F8Represents the weighted average price of the shares sold. The prices actually received ranged from $173.76 to $174.71 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F9Represents shares acquired through ongoing participation in Cigna's 401(k) Plan.